跳至主要内容
临床试验/NCT00589537
NCT00589537Unknown3 期

Trial of Imaging and Schedule in Seminoma Testis

Medical Research Council58 个研究点 分布在 1 个国家目标入组 660 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
3 期
入组人数
660
试验地点
58
主要终点
Proportion of patients relapsing with Royal Marsden Hospital stage IIC or greater disease

研究概览

简要总结

RATIONALE: Imaging procedures, such as MRI and CT scan, may find recurrent cancer. It is not yet known which MRI or CT scan schedule is more effective in finding recurrent cancer.

PURPOSE: This randomized phase III trial is comparing four different MRI and CT scan schedules in patients with stage I seminoma of the testicle.

详细描述

OBJECTIVES:

  • To assess whether a reduced computed tomography (CT) schedule or magnetic resonance imaging (MRI) could be used as safe and effective alternatives to standard CT-based surveillance in the management of patients with stage I seminoma of the testis.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 4 surveillance arms.

  • Arm I: Patients undergo computed tomography (CT) scan of the abdomen/retroperitoneum* at 6, 12, 18, 24, 36, 48, and 60 months in the absence of disease progression.
  • Arm II: Patients undergo CT scan of the abdomen/retroperitoneum* at 6, 18, and 36 months in the absence of disease progression.
  • Arm III: Patients undergo magnetic resonance imaging (MRI) of the abdomen/retroperitoneum* at 6, 12, 18, 24, 36, 48, and 60 months in the absence of disease progression.
  • Arm IV: Patients undergo MRI of the abdomen/retroperitoneum* at 6, 18, and 36 months in the absence of disease progression.

NOTE: *Patients with a history of ipsilateral inguino-scrotal surgery also undergo imaging of the pelvis.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Diagnostic

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Proportion of patients relapsing with Royal Marsden Hospital stage IIC or greater disease

次要结局

  • Difference in mean abdominal mass size at relapse between computed tomography (CT) scan and magnetic resonance imaging (MRI)
  • Time on surveillance before detection of relapse
  • Prospective identification of first modality to detect relapse (patient symptom, clinical examination, tumor marker, chest x-ray, cross-sectional image)
  • Extent of relapse according to International Germ Cell Cancer Collaborative Group classification
  • Disease-free survival
  • Overall survival
  • Prospective evaluation of prognostic factors for relapse
  • Number of false positive MRIs
  • Resource use and costs

研究者

申办方类型
Other Gov

研究点 (58)

Loading locations...

相似试验